Browse the corpus

REFERENCES Allie DE, Lirtzman MD, Wyatt CH, et al, “Bivalirudin as a Foundation Anticoagulant in Peripheral Vascular Disease: A Safe and Feasible Alternative for Renal and Iliac Interventions," J Invasive Cardiol , 2003, 15(6):334-42. [PubMed 12777673 ] Anderson JL, Adams CD, Antman EM, et al, “ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration With the American College of Emergency Physicians, The Society of Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons,” Circulation , 2007, 116(7):e148-304. [PubMed 17679616 ] Antman EM, Anbe SC, Alpert JS, et al, “ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction),” Circulation , 2004, 110(5):588-636. [PubMed 15289388 ] Antman EM, “Should Bivalirudin Replace Heparin During Percutaneous Coronary Interventions?” JAMA , 2003, 289:903-5. [PubMed 12588276 ] Aggarwal A, Sobel BE, and Schneider DJ, “Decreased Platelet Reactivity in Blood Anticoagulated With Bivalirudin or Enoxaparin Compared With Unfractionated Heparin: Implications for Coronary Intervention,” J Thromb Thrombolysis , 2002, 13:161-5. [PubMed 12355033 ] Bittl JA, Chaitman BR, Feit F, et al, “Bivalirudin Versus Heparin During Coronary Angioplasty for Unstable or Postinfarction Angina: Final Report Reanalysis of the Bivalirudin Angioplasty Study,” Am Heart J , 2001, 142:952-9. [PubMed 11717596 ] Bittl JA, Strony J, Brinker JA, et al, “Treatment With Bivalirudin (Hirulog) as Compared With Heparin During Coronary Angioplasty for Unstable or Postinfarction Angina. Hirulog Angioplasty Study Investigators,” N Engl J Med , 1995, 333(12):764-9. [PubMed 7643883 ]

Bittl JA, Chaitman BR, Feit F, et al, “Bivalirudin Versus Heparin During Coronary Angioplasty for Unstable or Postinfarction Angina: Final Report Reanalysis of the Bivalirudin Angioplasty Study,” Am Heart J , 2001, 142:952-9. [PubMed 11717596 ] Bittl JA, Strony J, Brinker JA, et al, “Treatment With Bivalirudin (Hirulog) as Compared With Heparin During Coronary Angioplasty for Unstable or Postinfarction Angina. Hirulog Angioplasty Study Investigators,” N Engl J Med , 1995, 333(12):764-9. [PubMed 7643883 ] Dager WE, Dougherty JA, Nguyen PH, et al, “Heparin-Induced Thrombocytopenia: Treatment Options and Special Considerations,” Pharmacotherapy , 2007, 27(4):564-87. [PubMed 17381384 ] Dangas GD, Mehran R, Nikolsky E, et al, “Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction: The HORIZONS-SWITCH Analysis,” J Am Coll Cardiol , 2001, 57(23):2309-11. [PubMed 21636031 ] Davis Z, Anderson R, Short D, et al, “Favorable Outcome With Bivalirudin Anticoagulation During Cardiopulmonary Bypass,” Ann Thorac Surg , 2003, 75(1):264-5. [PubMed 12537226 ] Dyke CM, Aldea G, Koster A, et al, “Off-Pump Coronary Artery Bypass With Bivalirudin for Patients With Heparin-Induced Thrombocytopenia or Antiplatelet Factor Four/Heparin Antibodies,” Ann Thorac Surg , 2007, 84(3):836-40. [PubMed 17720385 ] Dyke CM, Smedira NG, Koster A, et al, “A Comparison of Bivalirudin to Heparin With Protamine Reversal in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: The EVOLUTION-ON Study,” J Thorac Cardiovasc Surg , 2006, 131(3):533-9. [PubMed 16515902 ] Fuchs J and Cannon CP, “Hirulog in the Treatment of Unstable Angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 Trial,” Circulation , 1995, 92(4):727-33. [PubMed 7641350 ] Guyatt GH, Akl EA, Crowther M, et al, “Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest , 2012, 141(2 Suppl):7-47. [PubMed 22315257 ]

Fuchs J and Cannon CP, “Hirulog in the Treatment of Unstable Angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 Trial,” Circulation , 1995, 92(4):727-33. [PubMed 7641350 ] Guyatt GH, Akl EA, Crowther M, et al, “Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest , 2012, 141(2 Suppl):7-47. [PubMed 22315257 ] Jneid H, Anderson JL, Wright RS, et al, “2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation , 2012, 126(7):875-910. [PubMed 22800849 ] Kiser TH and Fish DN, “Evaluation of Bivalirudin Treatment for Heparin-Induced Thrombocytopenia in Critically Ill Patients With Hepatic and/or Renal Dysfunction,” Pharmacotherapy , 2006, 26(4):452-60. [PubMed 16553502 ] Kiser TH, Burch JC, Klem PM, et al, “Safety, Efficacy, and Dosing Requirements of Bivalirudin in Patients With Heparin-induced Thrombocytopenia,” Pharmacotherapy , 2008, 28(9):1115-24. [PubMed 18752382 ] Koster A, Chew D, Grundel M, et al, “An Assessment of Different Filter Systems for Extracorporeal Elimination of Bivalirudin: An In Vitro Study,” Anesth Analg , 2003, 96(5):1316-19. [PubMed 12707125 ] Koster A, Chew D, Grundel M, et al, “Bivalirudin Monitored With the Ecarin Clotting Time for Anticoagulation During Cardiopulmonary Bypass,” Anesth Analg , 2003, 96(2): 383-6. Koster A, Dyke CM, Aldea G, et al, “Bivalirudin During Cardiopulmonary Bypass in Patients With Previous or Acute Heparin-Induced Thrombocytopenia and Heparin Antibodies: Results of the CHOOSE-ON Trial,” Ann Thorac Surg , 2007, 83(2):572-7. [PubMed 17257990 ] Koster A, Spiess B, Chew DP, et al. “Effectiveness of Bivalirudin as a Replacement for Heparin During Cardiopulmonary Bypass in Patients Undergoing Coronary Artery Bypass Grafting,” Am J Cardiol , 2004, 93(3):356-9. [PubMed 14759391 ]

Koster A, Dyke CM, Aldea G, et al, “Bivalirudin During Cardiopulmonary Bypass in Patients With Previous or Acute Heparin-Induced Thrombocytopenia and Heparin Antibodies: Results of the CHOOSE-ON Trial,” Ann Thorac Surg , 2007, 83(2):572-7. [PubMed 17257990 ] Koster A, Spiess B, Chew DP, et al. “Effectiveness of Bivalirudin as a Replacement for Heparin During Cardiopulmonary Bypass in Patients Undergoing Coronary Artery Bypass Grafting,” Am J Cardiol , 2004, 93(3):356-9. [PubMed 14759391 ] Kushner FG, Hand M, Smith SC, et al, “2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” J Am Coll Cardiol , 2009, 54(23):2205-41. [PubMed 19942100 ] Levine GN, Bates ER, Blankenship JC, et al, “2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions,” Circulation , 2011, 124(23):e574-651. [PubMed 22064601 ] Lincoff AM, Bittl JA, Harrington RA, et al, “Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention. REPLACE-2 Randomized Trial,” JAMA , 2003, 289(7):853-63. [PubMed 12588269 ] Lincoff AM, Kleiman NS, Kereiakes DJ, et al, “Long-Term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization: REPLACE-2 Randomized Trial,” JAMA , 2004, 292(6):696-703. [PubMed 15304466 ] Lincoff AM, Kleiman NS, Kottke-Marchant K, et al, “Bivalirudin With Planned or Provisional Abciximab Versus Low-Dose Heparin and Abciximab During Percutaneous Coronary Revascularization: Results of the Comparison of Abciximab Complications With Hirulog for Ischemic Events Trial (CACHET),” Am Heart J , 2002, 143(5):847-53. [PubMed 12040347 ]

Lincoff AM, Kleiman NS, Kottke-Marchant K, et al, “Bivalirudin With Planned or Provisional Abciximab Versus Low-Dose Heparin and Abciximab During Percutaneous Coronary Revascularization: Results of the Comparison of Abciximab Complications With Hirulog for Ischemic Events Trial (CACHET),” Am Heart J , 2002, 143(5):847-53. [PubMed 12040347 ] Linkins L, Dans AL, Moores LK, et al, “Treatment and Prevention of Heparin-Induced Thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest , 2012, 141(2 Suppl):e495-530. [PubMed 22315270 ] Merry AF, Raudkivi PJ, Middleton NG, et al, “Bivalirudin Versus Heparin and Protamine in Off-Pump Coronary Artery Bypass Surgery,” Ann Thorac Surg , 2004, 77:925-31. [PubMed 14992900 ] Neuhaus KL, Molhoek GP, Zeymer U, et al, “Recombinant Hirudin (Lepirudin) for the Improvement of Thrombolysis With Streptokinase in Patients With Acute Myocardial Infarction: Results of the HIT-4 Trial,” J Am Coll Cardiol , 1999, 34(4):966-73. [PubMed 10520777 ] O'Gara PT, Kushner FG, Ascheim DD, et al, "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines," Circulation , 2012, 127(4):e362-425. [PubMed 3247304 ] Robson R, “The Use of Bivalirudin in Patients With Renal Impairment,” J Invasive Cardiol , 2000, 12:33F-36F. [PubMed 11156732 ] Shammas NW, Lemke JH, Dippel EJ, et al, “Bivalirudin in Peripheral Vascular Interventions: A Single Center Experience,” J Invasive Cardiol , 2003, 15(7):401-4. [PubMed 12840239 ] Smedira NG, Dyke CM, Koster A, et al, “Anticoagulation With Bivalirudin For Off-Pump Coronary Artery Bypass Grafting: The Results Of The EVOLUTION-OFF Study,” J Thorac Cardiovasc Surg , 2006, 131(3):686-92. [PubMed 16515924 ] Stone GW, McLaurin BT, Cox DA, et al, “Bivalirudin for Patients With Acute Coronary Syndromes,” N Engl J Med , 2006, 355(21):2203-16. [PubMed 17124018 ] Stone GW, Witzenbichler B, Guagliumi G, et al, “Bivalirudin During Primary PCI in Acute Myocardial Infarction,” N Engl J Med , 2008, 358(21):2218-30. [PubMed 18499566 ]

Stone GW, McLaurin BT, Cox DA, et al, “Bivalirudin for Patients With Acute Coronary Syndromes,” N Engl J Med , 2006, 355(21):2203-16. [PubMed 17124018 ] Stone GW, Witzenbichler B, Guagliumi G, et al, “Bivalirudin During Primary PCI in Acute Myocardial Infarction,” N Engl J Med , 2008, 358(21):2218-30. [PubMed 18499566 ] Tsu LV and Dager WE, “Bivalirudin Dosing Adjustments for Reduced Renal Function With or Without Hemodialysis in the Management of Heparin-Induced Thrombocytopenia,” Ann Pharmacother , 2011, 45(10):1185-92. [PubMed 21881032 ] Vasquez JC, Vichiendilokkul A, Mahmood S, et al, “Anticoagulation With Bivalirudin During Cardiopulmonary Bypass in Cardiac Surgery,” Ann Thorac Surg , 2002, 74(6):2177-9. [PubMed 12643418 ] Topic 8792 Version 50.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1102-222.190.118.195-1E1E8CC54B-S244013.14]